Health Sciences Group, Inc.
HESG · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.03 | 0.00 | -1.03 |
| FCF Yield | -1.39% | -1.08% | -1.31% | -3.67% |
| EV / EBITDA | -7.47 | 2.16 | -5.78 | -27.83 |
| Quality | ||||
| ROIC | 90.73% | -181.61% | 479.78% | 0.00% |
| Gross Margin | 34.94% | 27.13% | 26.26% | 23.63% |
| Cash Conversion Ratio | 0.05 | 0.04 | 0.06 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | -75.77% | -79.06% | -82.42% | -84.99% |
| Free Cash Flow Growth | -7.76% | 56.99% | 71.31% | 60.13% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | 0.18 | -0.23 | -0.88 |
| Interest Coverage | -8.33 | 11.01 | -11.04 | -0.99 |
| Efficiency | ||||
| Inventory Turnover | 0.06 | 0.08 | 0.20 | 0.30 |
| Cash Conversion Cycle | -4,989.43 | -2,850.53 | -1,151.05 | -559.28 |